EPFL spinout Lunaphore has received $2m in a series C extension provided by Swiss Entrepreneurs Fund, adding to an initial $23.6m tranche led by PHC Holdings three months ago.
Lunaphore, a Switzerland-based cancer research and diagnostics equipment spinout of EPFL, added CHF2m ($2m) to close a series C round already backed by medical products group PHC Holdings at $25.6m on Tuesday.
The extension was supplied by Swiss Entrepreneurs Fund, a joint investment vehicle formed by startup support organisation Swiss Entrepreneurs Foundation, insurance provider Swiss Mobiliar and investment banks Credit Suisse and UBS.
PHC Holdings led the $23.6m first tranche with contributions from Alpana Ventures and Occident. The…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
